Application of V011-9701 in the preparation of plant pathogenic fungal inhibitors

By developing the small molecule compound V011-9701 to target and bind to PMT protein, blocking the O-mannosylation modification process of fungi, the problem of increased pathogen resistance and lack of targeted inhibitors in existing technologies has been solved, and efficient control of plant pathogenic fungi such as corn anthracnose has been achieved.

CN123100634APending Publication Date: 2026-11-17INST OF PLANT PROTECTION CHINESE ACAD OF AGRI SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611601398.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-10-16
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing chemical fungicides lead to increased resistance in pathogens, resulting in high biosafety and ecological risks. There is a lack of small molecule inhibitors that target O-mannosyltransferases of plant pathogenic fungi, making it difficult to effectively control agricultural pests such as corn anthracnose.

Method used

We developed a small molecule compound, V011-9701, which inhibits the growth, development, and pathogenicity of pathogens by binding to PMT proteins and blocking the O-mannosylation modification process of fungi.

Benefits of technology

V011-9701 targets and binds to multiple subtypes of PMT1, PMT2, and PMT4 proteins of *Anthracnose macrantha*, exhibiting excellent specific antibacterial activity and broad-spectrum antifungal effects, effectively controlling corn anthracnose and other plant pathogenic fungi.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123100634A_ABST
    Figure CN123100634A_ABST
Patent Text Reader

Abstract

This invention belongs to the field of fungal disease control technology, specifically relating to the application of V011-9701 in the preparation of plant pathogenic fungal inhibitors. In this invention, V011-9701 inhibits the growth, development, and pathogenicity of pathogens by binding to PMT proteins and blocking the O-mannosylation modification process of fungi.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of plant pathogenic fungal disease control technology, specifically involving the application of V011-9701 in the preparation of plant pathogenic fungal inhibitors. Background Technology

[0002] Plant fungal diseases are a major cause of crop yield reduction, excessive fungal toxin levels, and deterioration in agricultural product quality. Currently, chemical control remains the core method for controlling crop fungal diseases in the field. However, long-term and excessive application of traditional chemical fungicides has led to a year-on-year increase in pathogen resistance and a continuous decline in control efficacy. Simultaneously, some commercially available fungicides suffer from poor biosafety and high ecological risks, and existing control agents and systems have shown significant technical bottlenecks. Therefore, identifying novel safe targets for plant pathogenic fungi and developing highly targeted, green, and low-toxicity fungicides are urgent needs in the field of green control of crop fungal diseases.

[0003] Anthracnose of maize is a typical semi-living, vegetative plant pathogenic fungus that primarily infects important gramineous crops such as maize and sorghum, posing a serious threat to food security. This pathogen can complete its infection transition from live to dead parasitism by regulating key physiological processes such as glycosylation modification and effector protein secretion, thereby successfully infecting host plants and causing disease. Protein O-mannosyltransferase (PMT) is a key enzyme mediating O-glycosylation modification of fungal proteins. Three PMT family functional genes—PMT1, PMT2, and PMT4—have been identified in the Anthracnose genome. All three are located in the endoplasmic reticulum and jointly undertake the initiation of O-mannosylation modification of pathogenic proteins, participating in the regulation of the entire process of pathogenic vegetative growth, cell wall construction, and pathogenic infection.

[0004] Existing research indicates that each gene in the PMT family plays a specific and indispensable role in regulating the growth, development, and pathogenicity of *Anthracnose macrantha*. Specifically, the PMT1 gene knockout mutant strain exhibits a 20% decrease in mycelial growth rate compared to the wild-type strain, and its appressorium loses its ability to penetrate the host epidermis. The PMT2 gene knockout mutant strain results in malformed mycelial morphology, a significant decrease in sporulation capacity, and defective appressorium development, completely losing its infection penetration function; it is a key gene essential for maintaining the normal pathogenicity of *Anthracnose macrantha*. The PMT4 gene knockout mutant strain shows the most significant inhibitory effect on growth and development. Therefore, targeting and inhibiting the function of PMT family proteins can effectively block the growth, development, and pathogenic infection processes of *Anthracnose macrantha*, achieving effective control of maize anthracnose. Furthermore, since PMT homologous genes do not exist in the plant genome, this target possesses natural species specificity and host safety, with no risk of off-target effects, making it a novel and green target for fungicides with great application potential.

[0005] Current research has yielded a series of PMT inhibitors designed and synthesized using rhodanine-3-acetic acid as the core, but existing candidate compounds generally suffer from significant drawbacks: First, their molecular weights are generally large, ranging from 555 to 635 Da, limiting their potential as pharmaceuticals and their value for field applications. Second, the activity verification of existing PMT inhibitors is limited to non-plant pathogenic fungal systems such as Pichia pastoris, and has not been conducted to verify their antifungal activity and targeting function against agricultural harmful plant pathogenic fungi. To date, there are no reports on small-molecule inhibitors targeting PMT proteins in plant pathogenic fungi, severely hindering the creation and industrial application of green fungicides targeting PMT. Summary of the Invention

[0006] In view of this, the purpose of this invention is to provide the application of V011-9701 in the preparation of small molecule inhibitors targeting plant pathogenic fungi O-mannosyltransferase. In this invention, V011-9701 blocks the O-mannosylation modification process of fungi by binding to PMT protein, thereby inhibiting the growth, development and pathogenicity of pathogens.

[0007] To achieve the above objectives, the present invention provides the following technical solution: This invention provides the application of V011-9701 in the preparation of inhibitors for plant pathogenic fungi, wherein V011-9701 has the structure shown in Formula 1: Formula 1.

[0008] Preferably, the plant pathogenic fungi include at least one of the genera Fusarium, Anthracnose, and Megaloceros.

[0009] Preferably, the anthrax genus includes at least one of Anthrax zeylans, Anthrax oxysporum, and Anthrax collodion.

[0010] Preferably, the Fusarium genus includes at least one of Fusarium graminearum, Fusarium pseudograminearum, and Fusarium oxysporum.

[0011] Preferably, the genus *Ceratophyllum* includes *Bacillus oryzae*.

[0012] Preferably, the plant pathogenic fungal inhibitor is an aqueous dispersion of V011-9701.

[0013] Preferably, the concentration of the aqueous dispersion of V011-9701 is 5~20 μg / mL.

[0014] Preferably, the aqueous dispersion of V011-9701 further includes an emulsifier.

[0015] Preferably, the emulsifier is Tween 80.

[0016] Preferably, the mass fraction of the emulsifier in the aqueous dispersion of V011-9701 is 0.05%.

[0017] Preferably, the plant pathogenic fungal inhibitor is used by foliar spraying.

[0018] This invention provides the application of V011-9701 in the preparation of inhibitors for plant pathogenic fungi, wherein V011-9701 has the structure shown in Formula 1: Formula 1.

[0019] Beneficial effects: To address the gaps and deficiencies in existing technologies, this invention utilizes large-scale virtual screening combined with indoor bioactivity assays to screen and obtain the small molecule compound V011-9701. V011-9701 is a small molecule heterocyclic derivative that can serve as a small molecule inhibitor targeting O-mannosyltransferase in plant pathogenic fungi. It can inhibit the growth, development, and pathogenicity of pathogens by binding to PMT proteins and blocking the O-mannosylation modification process of fungi.

[0020] Experimental results have shown that this compound can target and bind to multiple subtypes of PMT1, PMT2, and PMT4 proteins of *Anthracnose zeylans*, exhibiting both excellent specific antibacterial activity and broad-spectrum antifungal effects. It effectively fills the technological gap in the existing technology of lacking small molecule inhibitors targeting PMT proteins of plant pathogenic fungi, and can provide a key lead structure for the development of novel green and highly selective fungicides targeting PMT proteins. Attached Figure Description

[0021] Figure 1 A schematic diagram of the screening process for PMT small molecule inhibitors (a), an inhibition rate diagram (b), a hyphal inhibition diagram of V011-9701 (c), and the structural formulas of 8 compounds (d). Figure 2 The graph shows the inhibitory effect of V011-9701 on the mycelial growth of wild-type *Anthracis maize* strain. Figure 3 The graph shows the inhibitory effect of V011-9701 on the mycelial growth of the PMT gene knockout mutant strain of Bacillus anthracis in maize. Figure 4 The graph shows the inhibitory effect of V011-9701 on the mycelial growth of the PMT gene knockout mutant of Bacillus anthracis in maize. Figure 5 The graph shows the inhibitory effect of V011-9701 on the occurrence of anthracnose in maize leaves; Figure 6 The image shows the inhibitory effect of V011-9701 on the mycelial growth of six plant pathogenic fungi. Detailed Implementation

[0022] This invention provides the application of V011-9701 in the preparation of inhibitors for plant pathogenic fungi, wherein V011-9701 has the structure shown in Formula 1: Formula 1.

[0023] Unless otherwise specified, the present invention does not have special requirements on the source of raw materials used, and commercially available products well known to those skilled in the art can be used.

[0024] As one embodiment, the molecular formula of V011-9701 is: C 26 H 21 F₂N₃O; Relative molecular weight: 429.165 g / mol; Physical properties: lipid solubility logP = 5.3, water solubility: 0.001784 mg / L; Vapor pressure: 6.48 × 10⁻⁶ -15 mmHg; Organic carbon adsorption coefficient log K OC =6.056; bioaccumulation coefficient logBCF=3.552. Structure of V011-9701: Characteristic core structure of fluorinated substituted aromatic ring, amide and heterocyclic amino group.

[0025] In one embodiment, the V011-9701 inhibits the growth and development of pathogens and their pathogenicity by binding to PMT proteins and blocking the O-mannosylation modification process of fungi; the PMT proteins include at least one of PMT1, PMT2 and PMT4.

[0026] In one embodiment, the plant pathogenic fungus includes Fusarium ( ). Fusarium spp.), Anthrax genus ( Colletotrichum spp.) and the genus *Ceratophyllum* ( Magnaporthe At least one of the genus *Anthrax* (spp.); the *Anthrax* genus includes *Anthrax zeylanica* (spp.). Colletotrichum graminicola ), Anthrax bacillus ( Colletotrichum acutatum ) and Colletotrichum anthracnose ( Colletotrichum gloeosporioides At least one of the following: Fusarium species; the Fusarium genus includes Fusarium graminearum (Fusarium graminearum). Fusarium graminearum ), Fusarium graminearum ( Fusarium pseudograminearum ) and Fusarium oxysporum ( Fusarium oxysporum At least one of the following: *Ceratophyllum* genus, including *Oryza sativa* (*Oryza sativa*). Magnaporthe oryzae ).

[0027] The *Fusarium graminearum* (PH-1), *Fusarium pseudograminearum* (FpWT), *Colletotrichum gloeosporioides* (LN-48), and *Colletotrichum oxysporum* (HTTJ1) in this invention were kindly donated by Professor Liu Feng of the College of Plant Protection, Shandong Agricultural University, and are deposited in the laboratory of the College of Plant Protection, Shandong Agricultural University. *Fusarium oxysporum* (SG-15) was kindly donated by Professor Gao Kexiang of the College of Plant Protection, Shandong Agricultural University, and is deposited in the laboratory of the College of Plant Protection, Shandong Agricultural University. *Anthracnose maize* (TZ-3) and *Oryza sativa* (CUY11) were kindly donated by Professor Liu Wende of the Institute of Plant Protection, Chinese Academy of Agricultural Sciences, and are deposited in the laboratory of the Institute of Plant Protection, Chinese Academy of Agricultural Sciences.

[0028] Fusarium graminearum, see Ma, D., Wang, G., Zhu, J., Mu, W., Dou, D., & Liu, F. (2022). Green leaf volatile trans-2-hexenal inhibits the growth of Fusariumgraminearum by inducing membrane damage, ROS accumulation, and celldysfunction. Journal of Agricultural and Food Chemistry, 70(18), 5646-5657. For *Colletotrichum gloeosporioides* and *Colletotrichum axyridis*, see He, L., Li, X., Gao, Y., Li, B., Mu, W., & Liu, F. (2019). Characterization and fungicide sensitivity of *Colletotrichum gloeosporioides* pp. from different hosts in Shandong, China. *Plant Disease*, 103(1), 34-43. Pseudomonas graminearum See Wang, G.; Chem. 2026, 74, 10989–11000. For reference on Colletotrichum graminicola, see Mei, J., Ning, N., Yang, Y., Zhou, SQ, & Liu, WD (2025). PMT family mannosyltransferase-mediated protein O-mannosylation is required for the development and pathogenicity of Colletotrichum graminicola. Phytopathology Research, 7(1), 40. For Fusarium oxysporum, see Li Xiaofang, Tian Yehan, Peng Haiying, et al. Isolation, screening and identification of antagonistic actinomycetes for controlling Fusarium wilt in bitter gourd [J]. Chinese Journal of Applied Ecology, 2020, 31(11):3869-3879. For information on rice blast fungus, see Shi, X., Xie, X., Guo, Y. et al. A fungal core effector exploits the OsPUX8B.2–OsCDC48-6 module to suppress plant immunity. NatCommun 15, 2559 (2024). https: / / doi.org / 10.1038 / s41467-024-46903-7. In one embodiment, the plant pathogenic fungal inhibitor is an aqueous dispersion of V011-9701; the concentration of the aqueous dispersion of V011-9701 is 5~20 μg / mL, and in specific embodiments it is 5 μg / mL, 10 μg / mL or 20 μg / mL.

[0029] In one embodiment, the aqueous dispersion of V011-9701 further includes an emulsifier; the emulsifier is Tween 80; and the mass fraction of the emulsifier in the aqueous dispersion of V011-9701 is 0.05%.

[0030] As one implementation method, the plant pathogenic fungal inhibitor is used by foliar spraying.

[0031] In this invention, V011-9701 can simultaneously target multiple O-mannosyltransferase genes (PMT1, PMT2, PMT4) of *Anthracis maize*, and has an inhibitory effect on the growth of important crop pathogenic fungi such as *Fusarium graminearum*.

[0032] The technical solutions of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, but they should not be construed as limiting the scope of protection of the present invention.

[0033] Example 1 Virtual screening of compounds: In this study, 156,995 small molecule compounds were selected from multiple commercial compound libraries, including ChemDiv and InterBioScreen, as screening targets. Autodock Vina software was used to conduct virtual screening of the selected small molecule compounds and the PMT4 protein from *Anthracis maize*. Using a binding free energy ΔG < -8 kcal / mol as the screening threshold, 172 candidate small molecule compounds were initially obtained. Based on the principle of compound skeletal structural diversity, 8 structures were selected from these (see...). Figure 1 (See Table 1 for details) Representative candidate compounds (d) were selected for subsequent antibacterial activity verification tests. These eight candidate compounds were purchased from ChemDiv and Eximed.

[0034] Table 1. Detailed information on the 8 structures

[0035] (1) Validation of in vitro antibacterial activity The inhibitory effect of the tested compounds on the wild-type strain of *Anthracis maize* was determined using the mycelial growth rate method. 0.1 g of V011-9701 was weighed and dissolved thoroughly in 1 mL of dimethyl sulfoxide (DMSO) to prepare a solution with a concentration of 1.0 × 10⁻⁶. 5A stock solution of the compound was prepared at a concentration of μg / mL; the stock solution was serially diluted with deionized water to obtain a working solution of the compound at a concentration of 100 μg / mL. 1 mL of the working solution was thoroughly mixed with 9 mL of potato agarose (PDA) medium, poured into disposable plastic petri dishes, and allowed to solidify at room temperature to obtain a PDA plate containing the drug at a final concentration of 10 μg / mL. Additionally, PDA plates containing the same concentration of solvent were prepared as a control. Colonies of wild-type *Anthracnose maize* strains with good growth were selected, and mycelial cakes were collected from the edge of the colonies in areas with uniform mycelial growth. These mycelial cakes were inoculated onto the prepared PDA plates containing the drug and cultured at 25℃ for 3 days. After culture, the colony diameter of each group was measured, and the inhibition rate of the compound on the mycelial growth of wild-type *Anthracnose maize* strains was calculated. The antibacterial activity of the remaining 7 candidate compounds was determined using the same experimental method. The experimental results showed that ( Figure 1 Compound V011-9701 showed a significant inhibitory effect on the mycelial growth of wild-type *Anthracis maize* strain, with an inhibition rate of up to 25.9%. The other seven tested compounds showed weak inhibitory activity against wild-type *Anthracis maize* strains, with mycelial growth inhibition rates all below 10.0%.

[0036] (2) Determination of the antibacterial properties of V011-9701 against wild-type strains of Bacillus anthracis in maize This experiment used the aforementioned mycelial growth rate method to determine the inhibitory activity of compound V011-9701 on the mycelial growth of wild-type *Anthracis maize* strain. Previous experiments revealed that compound V011-9701 has high lipid solubility and poor water dispersibility, easily precipitating in aqueous systems. To improve its water dispersibility, during preparation, the concentration was adjusted to 1.0 × 10⁻⁶. 5 To improve the dispersibility and stability of V011-9701 stock solution, 0.05% Tween 80 was added at a concentration of μg / mL. Concentration gradients of V011-9701 solution were set at 0 μg / mL, 0.125 μg / mL, 0.25 μg / mL, 0.5 μg / mL, 1 μg / mL, and 2 μg / mL. Concentration and inhibition rate data were imported into DPS data analysis software, dose-response curves were fitted, and the half-maximal inhibitory concentration (EC50) of the compound against the tested strain was calculated. 50 The test results show that ( Figure 2 EC50 of V011-9701 on the mycelial growth of wild-type strain of *Anthracis maize* 50 The concentration was 0.5 μg / mL, indicating that the compound had a good inhibitory effect on the growth of wild-type *Anthracis maize* strains.

[0037] (3) Validation test of antibacterial activity of V011-9701 dependent on PMT protein To clarify the target-specific correlation of the antibacterial activity of V011-9701, this experiment determined the antibacterial activity of this compound against PMT gene knockout mutants (△PMT1, △PMT2, △PMT4) and corresponding gene complementation strains (C-PMT1, C-PMT2, C-PMT4) of *Agrostis cuspidata*. For the PMT gene knockout mutant strains, V011-9701 concentration gradients were set at 0 μg / mL, 0.625 μg / mL, 1.25 μg / mL, 2.5 μg / mL, 5 μg / mL, and 10 μg / mL; for the PMT gene knockout mutant complementation strains, the V011-9701 concentration gradients were 0 μg / mL, 0.125 μg / mL, 0.25 μg / mL, 0.5 μg / mL, 1 μg / mL, and 2 μg / mL. The mycelial growth inhibition rate of each strain was determined using the mycelial growth rate method described above. The dose-response equation was fitted using DPS software, and the EC50 corresponding to each group of strains was calculated. 50 Value. The test results show ( Figure 3 EC50 of strains V011-9701 against ΔPMT1, ΔPMT2, and ΔPMT4 50 The concentrations of 4.5 μg / mL, 3.5 μg / mL, and 1.5 μg / mL, respectively, showed a 2.0–8.0-fold increase in resistance compared to the wild-type strain, with a significant decrease in antibacterial activity. The EC50 values ​​of V011-9701 against C-PMT1, C-PMT2, and C-PMT4 strains were [not specified in the original text]. 50 The concentrations were 0.7 μg / mL, 0.7 μg / mL, and 0.6 μg / mL, respectively. Figure 4 The difference in sensitivity between the strain and the wild-type strain was less than 40.0%, and the antibacterial activity was basically restored to the level of the wild-type strain. These results indicate that the antibacterial activity of V011-9701 against *Anthracis maize* depends on the normal expression and function of the PMT protein.

[0038] (4) Determination of the leaf disease control effect of V011-9701 against corn anthracnose The efficacy of V011-9701 against maize anthracnose was evaluated using a maize leaf inoculation system. Nutrient soil and vermiculite were mixed at a 1:1 volume ratio, packaged, and used for seedling raising. The susceptible maize variety Zhengdan 958 was sown and cultured under standard conditions until the two-leaf-one-heart stage. Wild-type strains of *Anthracnose* were inoculated onto oat-based solid culture medium and cultured at a constant temperature until sporulation. Conidia were collected by washing with sterile water, and the spore suspension concentration was calibrated using a hemocytometer and adjusted to a final concentration of 1.0 × 10⁻⁶. 5 / mL. V011-9701 solutions with mass concentrations of 5 μg / mL, 10 μg / mL, and 20 μg / mL were prepared, with water as a blank control. The second true leaves of uniformly growing corn plants were selected, and each concentration of solution was sprayed evenly. After natural drying, 10 μL of spore suspension was dropped into the center of the leaf. The inoculated leaves were first placed in a dark, constant-temperature, moist environment for 24 hours to promote pathogen infection, and then transferred to conventional light conditions for further culture. Six days after inoculation, the disease phenotype was observed and photographed. ImageJ software was used to quantitatively determine the leaf lesion area in each group, and the disease control effect at different drug concentrations was calculated. The experimental results showed ( Figure 5 Within the concentration range of 5~20μg / mL, V011-9701 showed a control effect of 30.6~86.4% against corn anthracnose, indicating that the compound can effectively inhibit the infection of corn anthracnose fungus on corn leaves and has a good disease prevention effect.

[0039] (5) Determination of the broad-spectrum antifungal activity of V011-9701 against plant pathogenic fungi To verify the broad-spectrum antifungal activity of the compound, this example uses the aforementioned mycelial growth rate method to determine the antifungal effect of V011-9701 against various important agricultural pathogenic fungi. The tested strains included: *Fusarium graminearum*, *Fusarium pseudograminearum*, *Fusarium oxysporum*, *Anthracnose spp.*, *Colletotrichum gloeosporioides*, and *Bacillus oryzae*. Through drug gradient treatment, mycelial growth statistics, and dose-response fitting analysis, the EC50 of V011-9701 against each pathogenic fungus was calculated. 50 Value. The test results show ( Figure 6 V011-9701 EC50 assay for the above six typical plant pathogenic fungi 50 The concentration ranged from 3.1 to 11.4 μg / mL, indicating that the compound has clear antibacterial activity against various crop pathogenic fungi such as Fusarium, Anthracnose, and Rice blast fungus, and has the potential for broad-spectrum control of fungal diseases.

[0040] Although the above embodiments have provided a detailed description of the present invention, they are only some embodiments of the present invention and not all embodiments. People can obtain other embodiments based on these embodiments without creative effort, and these embodiments all fall within the protection scope of the present invention.

Claims

1. The application of V011-9701 in the preparation of inhibitors for plant pathogenic fungi, characterized in that, V011-9701 has the structure shown in Formula 1: Formula 1; The plant pathogenic fungus is *Anthracnose zeylans* (… Colletotrichum graminicola ), Anthrax bacillus ( Colletotrichum acutatum ), Colloidal anthrax bacteria ( Colletotrichum gloeosporioides Fusarium graminearum ( ), Fusarium graminearum ), Fusarium graminearum ( Fusarium pseudograminearum Fusarium oxysporum ( Fusarium oxysporum ) and rice blast fungus ( Magnaporthe oryzae At least one of the following; The method of using the plant pathogenic fungal inhibitor is foliar spraying.

2. The application according to claim 1, characterized in that, The plant pathogenic fungal inhibitor is an aqueous dispersion of V011-9701.

3. The application according to claim 2, characterized in that, The concentration of the aqueous dispersion of V011-9701 is 5~20 μg / mL.

4. The application according to claim 2, characterized in that, The aqueous dispersion of V011-9701 also includes an emulsifier; the emulsifier is Tween 80.

5. The application according to claim 4, characterized in that, The emulsifier has a mass fraction of 0.05% in the aqueous dispersion of V011-9701.